The roles of histamine and its receptor ligands in central nervous system disorders: An update
- PMID: 28223162
- DOI: 10.1016/j.pharmthera.2017.02.039
The roles of histamine and its receptor ligands in central nervous system disorders: An update
Abstract
The neurotransmitter histamine receives less attention compared with other biogenic amines, because of its moderate action in the central nervous system (CNS). However, recent evidence suggests that histamine plays an important role in multiple CNS disorders including insomnia, narcolepsy, Parkinson's diseases, schizophrenia, Alzheimer's disease, and cerebral ischemia. New insights are emerging into the potential roles of histamine receptors as targets for the treatment of these diseases. Although some histamine related agents have failed in clinical trials, current preclinical studies suggest that this neurotransmitter may still have extensive applications in treating CNS disorders, however, advanced studies are warranted. This review summarizes findings from animal models and clinical research on the role of histamine and its receptor ligands in the brain for treatment of CNS disorders. The development of novel histamine receptor ligands and gaining an in-depth understanding of their potential mechanisms are necessary stepping stones to unlock their wide-ranging applications in the clinical arena.
Keywords: Alzheimer's disease; Cerebral ischemia; Histamine; Histamine receptor; Parkinson's diseases; Schizophrenia; Sleep disorders.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
The Histaminergic System in Neuropsychiatric Disorders.Biomolecules. 2021 Sep 11;11(9):1345. doi: 10.3390/biom11091345. Biomolecules. 2021. PMID: 34572558 Free PMC article. Review.
-
Histamine and astrocyte function.Pharmacol Res. 2016 Sep;111:774-783. doi: 10.1016/j.phrs.2016.07.035. Epub 2016 Jul 27. Pharmacol Res. 2016. PMID: 27475882 Review.
-
Histamine pharmacology and new CNS drug targets.CNS Neurosci Ther. 2011 Dec;17(6):620-8. doi: 10.1111/j.1755-5949.2010.00212.x. Epub 2010 Nov 22. CNS Neurosci Ther. 2011. PMID: 22070192 Free PMC article. Review.
-
Histamine in neurotransmission and brain diseases.Adv Exp Med Biol. 2010;709:95-107. doi: 10.1007/978-1-4419-8056-4_10. Adv Exp Med Biol. 2010. PMID: 21618891 Review.
-
Histamine and histamine receptors in Tourette syndrome and other neuropsychiatric conditions.Neuropharmacology. 2016 Jul;106:85-90. doi: 10.1016/j.neuropharm.2015.08.019. Epub 2015 Aug 14. Neuropharmacology. 2016. PMID: 26282120 Review.
Cited by
-
Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder.Pharmaceuticals (Basel). 2024 Jun 25;17(7):831. doi: 10.3390/ph17070831. Pharmaceuticals (Basel). 2024. PMID: 39065682 Free PMC article. Review.
-
Histamine H1 receptors in dentate gyrus-projecting cholinergic neurons of the medial septum suppress contextual fear retrieval in mice.Nat Commun. 2024 Jul 10;15(1):5805. doi: 10.1038/s41467-024-50042-4. Nat Commun. 2024. PMID: 38987240 Free PMC article.
-
A Closer Look at Histamine in Drosophila.Int J Mol Sci. 2024 Apr 18;25(8):4449. doi: 10.3390/ijms25084449. Int J Mol Sci. 2024. PMID: 38674034 Free PMC article. Review.
-
Histaminergic System and Vestibular Function in Normal and Pathological Conditions.Curr Neuropharmacol. 2024;22(11):1826-1845. doi: 10.2174/1570159X22666240319123151. Curr Neuropharmacol. 2024. PMID: 38504566 Free PMC article. Review.
-
The Gut-Brain Axis in Schizophrenia: The Implications of the Gut Microbiome and SCFA Production.Nutrients. 2023 Oct 16;15(20):4391. doi: 10.3390/nu15204391. Nutrients. 2023. PMID: 37892465 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
